Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $6,621,221 | $3,322,273 | $4,385,120 | $5,056,862 |
| - Cash | $3,598,876 | $3,621,806 | $4,010,067 | $4,480,438 |
| + Debt | $1,027,090 | $974,009 | $1,124,895 | $1,256,657 |
| Enterprise Value | $4,049,435 | $674,476 | $1,499,948 | $1,833,081 |
| Revenue | $1,146,203 | $951,412 | $949,697 | $804,834 |
| % Growth | 20.5% | 0.2% | 18% | – |
| Gross Profit | $757,256 | $633,194 | $608,516 | $547,911 |
| % Margin | 66.1% | 66.6% | 64.1% | 68.1% |
| EBITDA | $304,115 | -$279,779 | $113,825 | -$128,710 |
| % Margin | 26.5% | -29.4% | 12% | -16% |
| Net Income | $102,603 | -$183,238 | -$33,424 | -$4,373 |
| % Margin | 9% | -19.3% | -3.5% | -0.5% |
| EPS Diluted | 0.011 | -0.02 | -0.004 | -0.001 |
| % Growth | 156.6% | -450% | -620% | – |
| Operating Cash Flow | -$95,275 | $207,427 | $36,460 | $171,169 |
| Capital Expenditures | -$27,088 | -$22,369 | -$48,336 | -$51,568 |
| Free Cash Flow | -$122,363 | $185,058 | -$11,876 | $119,601 |